134 related articles for article (PubMed ID: 30676087)
21. Quantitative analysis of the BRAF
Ashida A; Sakaizawa K; Mikoshiba A; Uhara H; Okuyama R
Int J Clin Oncol; 2016 Oct; 21(5):981-988. PubMed ID: 27041702
[TBL] [Abstract][Full Text] [Related]
22. [Detection of KRAS mutation in colorectal cancer patients' cfDNA with droplet digital PCR].
Luo Y; Li Y
Sheng Wu Gong Cheng Xue Bao; 2018 Mar; 34(3):407-420. PubMed ID: 29577691
[TBL] [Abstract][Full Text] [Related]
23. Extracellular vesicles or free circulating DNA: where to search for BRAF and cKIT mutations?
Klump J; Phillipp U; Follo M; Eremin A; Lehmann H; Nestel S; von Bubnoff N; Nazarenko I
Nanomedicine; 2018 Apr; 14(3):875-882. PubMed ID: 29288729
[TBL] [Abstract][Full Text] [Related]
24. Clinical validation and implementation of droplet digital PCR for the detection of BRAF mutations from cell-free DNA.
Arnolda R; Howlett K; Chan T; Raleigh J; Hatzimihalis A; Bell A; Fellowes A; Sandhu S; McArthur GA; Fox SB; Dawson SJ; Hewitt C; Jones K; Wong SQ
Pathology; 2022 Oct; 54(6):772-778. PubMed ID: 35618509
[TBL] [Abstract][Full Text] [Related]
25. Droplet digital PCR for detection of
Malicherova B; Burjanivova T; Grendar M; Minarikova E; Bobrovska M; Vanova B; Jasek K; Jezkova E; Kapinova A; Antosova M; Homola I; Pecova T; Lasabova Z; Plank L
Am J Transl Res; 2018; 10(11):3773-3781. PubMed ID: 30662627
[TBL] [Abstract][Full Text] [Related]
26. Utility of droplet digital polymerase chain reaction for TERT and BRAF mutational profiling of thyroid nodules.
Rosvall BR; Kostiuk M; Williams J; Matkin A; Harris J; Seikaly H; O'Connell DA; Biron VL
BMC Cancer; 2021 Oct; 21(1):1142. PubMed ID: 34702207
[TBL] [Abstract][Full Text] [Related]
27. Decalcification can cause the failure of BRAF molecular analyses and anti-BRAFV600E VE1 immunohistochemistry.
Bourhis A; Le Flahec G; Uguen A
Pathol Int; 2019 Apr; 69(4):219-223. PubMed ID: 30843305
[TBL] [Abstract][Full Text] [Related]
28. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
Piris A; Mihm MC; Hoang MP
Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
[TBL] [Abstract][Full Text] [Related]
29. Monitoring Melanoma Using Circulating Free DNA.
Diefenbach RJ; Lee JH; Rizos H
Am J Clin Dermatol; 2019 Feb; 20(1):1-12. PubMed ID: 30374893
[TBL] [Abstract][Full Text] [Related]
30. Circulating Tumor DNA Measurement by Picoliter Droplet-Based Digital PCR and Vemurafenib Plasma Concentrations in Patients with Advanced BRAF-Mutated Melanoma.
Garlan F; Blanchet B; Kramkimel N; Puszkiel A; Golmard JL; Noe G; Dupin N; Laurent-Puig P; Vidal M; Taly V; Thomas-Schoemann A
Target Oncol; 2017 Jun; 12(3):365-371. PubMed ID: 28527094
[TBL] [Abstract][Full Text] [Related]
31. Intra- and Inter-Tumoral Homogeneity of BRAF(V600E) Mutations in Melanoma Tumors.
Riveiro-Falkenbach E; Villanueva CA; Garrido MC; Ruano Y; García-Martín RM; Godoy E; Ortiz-Romero PL; Ríos-Martín JJ; Santos-Briz A; Rodríguez-Peralto JL
J Invest Dermatol; 2015 Dec; 135(12):3078-3085. PubMed ID: 26083553
[TBL] [Abstract][Full Text] [Related]
32. BRAFV600E immunopositive melanomas show low frequency of heterogeneity and association with epithelioid tumor cells: a STROBE-compliant article.
Verlinden I; van den Hurk K; Clarijs R; Willig AP; Stallinga CMHA; Roemen GMJM; van den Oord JJ; Zur Hausen A; Speel EM; Winnepenninckx VJL
Medicine (Baltimore); 2014 Dec; 93(28):e285. PubMed ID: 25526463
[TBL] [Abstract][Full Text] [Related]
33. Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patients.
Daniotti M; Vallacchi V; Rivoltini L; Patuzzo R; Santinami M; Arienti F; Cutolo G; Pierotti MA; Parmiani G; Rodolfo M
Int J Cancer; 2007 Jun; 120(11):2439-44. PubMed ID: 17315191
[TBL] [Abstract][Full Text] [Related]
34. Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA.
Rowlands V; Rutkowski AJ; Meuser E; Carr TH; Harrington EA; Barrett JC
Sci Rep; 2019 Sep; 9(1):12620. PubMed ID: 31477768
[TBL] [Abstract][Full Text] [Related]
35. Interlaboratory assessment of droplet digital PCR for quantification of BRAF V600E mutation using a novel DNA reference material.
Dong L; Wang X; Wang S; Du M; Niu C; Yang J; Li L; Zhang G; Fu B; Gao Y; Wang J
Talanta; 2020 Jan; 207():120293. PubMed ID: 31594564
[TBL] [Abstract][Full Text] [Related]
36. Detection of BRAF V600E mutation in fine-needle aspiration fluid of papillary thyroid carcinoma by droplet digital PCR.
Xu X; Ma X; Zhang X; Cao G; Tang Y; Deng X; Kang Z; Li M; Guan M
Clin Chim Acta; 2019 Apr; 491():91-96. PubMed ID: 30682328
[TBL] [Abstract][Full Text] [Related]
37. Ultrasensitive detection of BRAF mutations in circulating tumor DNA of non-metastatic melanoma.
Gouda MA; Polivka J; Huang HJ; Treskova I; Pivovarcikova K; Fikrle T; Woznica V; Dustin DJ; Call SG; Meric-Bernstam F; Pesta M; Janku F
ESMO Open; 2022 Feb; 7(1):100357. PubMed ID: 34942440
[TBL] [Abstract][Full Text] [Related]
38. Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients.
Pinzani P; Salvianti F; Cascella R; Massi D; De Giorgi V; Pazzagli M; Orlando C
Clin Chim Acta; 2010 Sep; 411(17-18):1319-24. PubMed ID: 20576522
[TBL] [Abstract][Full Text] [Related]
39. Assessment of BRAF
Pierry C; Caumont C; Blanchard E; Brochet C; Dournes G; Gros A; Bandres T; Verdon S; Marty M; Bégueret H; Merlio JP
Virchows Arch; 2018 Feb; 472(2):247-258. PubMed ID: 28711990
[TBL] [Abstract][Full Text] [Related]
40. Analytic and clinical validity of thyroid nodule mutational profiling using droplet digital polymerase chain reaction.
Biron VL; Matkin A; Kostiuk M; Williams J; Cote DW; Harris J; Seikaly H; O'Connell DA
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):60. PubMed ID: 30249281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
